Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Finding Study of Once or Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Immunomedics, Inc.
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT01605318
First received: May 22, 2012
Last updated: March 18, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)